Slaughter and May advised Pacific Equity Partners and The Carlyle Group on the joint acquisition of the iNova Pharmaceuticals business from Valeant Pharmaceuticals International, Inc. for US$930 million

Slaughter and May advised Pacific Equity Partners and The Carlyle Group on the Hong Kong aspects of the joint acquisition of the iNova Pharmaceuticals business from Valeant Pharmaceuticals International, Inc. for US$930 million.

iNova markets a diversified portfolio of prescription and OTC medicines and has operations in more than 15 countries worldwide.

Pacific Equity Partners is a leading Australian private equity firm with approximately AUD 3.5 billion in funds currently under management. 

The Carlyle Group is a global alternative asset manager with US$ 162 billion of assets under management.

Slaughter and May worked as a team with international team members from the following firms: Gilbert + Tobin (lead counsel, Australia), Allen and Gledhill (Singapore), Weerawong, Chinnavat & Partners (Thailand), Rahmat Lim & Partners (Malaysia), Anderson Mori & Tomotsune (Japan), SyCip Salazar Hernandez & Gatmaitan (Philippines), Bowmans and Adams & Adams (South Africa)